NCT07200323 Prevalence of Postpartum Depression Among Patients of the CHUM GARE Clinic
| NCT ID | NCT07200323 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Centre hospitalier de l'Université de Montréal (CHUM) |
| Condition | Post-partum Depression |
| Study Type | OBSERVATIONAL |
| Enrollment | 100 participants |
| Start Date | 2025-10-20 |
| Primary Completion | 2026-10 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 100 participants in total. It began in 2025-10-20 with a primary completion date of 2026-10.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Postpartum depression (PPD) is a frequent complication of the postnatal period but remains underdetected in routine clinical practice. This prospective clinical study, conducted at the high-risk pregnancy clinic of the CHUM, aims to estimate the prevalence of PPD among patients seen in postpartum follow-up. It also assesses the feasibility of implementing a standardized screening protocol that combines the administration of the Edinburgh Postnatal Depression Scale (EPDS) with a clinical decision-support algorithm to guide appropriate medical follow-up. The study also seeks to explore clinical characteristics associated with higher EPDS scores.
Eligibility Criteria
Inclusion Criteria: * Patients aged 18 years or more * Patient who gave birth within the last 4 weeks to 6 months * Ability to understand French or English and complete the EPDS questionnaire * Physically present at their post-partum visit at the clinic Exclusion Criteria: * Inability to comprehend and/or complete the EPDS * Declines participation or does not provide informed consent
Contact & Investigator
Anne Lavoie, MD
PRINCIPAL INVESTIGATOR
CHUM
Frequently Asked Questions
Who can join the NCT07200323 clinical trial?
This trial is open to female participants only, aged 18 Years or older, studying Post-partum Depression. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07200323 currently recruiting?
Yes, NCT07200323 is actively recruiting participants. Contact the research team at anne.lavoie.med@ssss.gouv.qc.ca for enrollment information.
Where is the NCT07200323 trial being conducted?
This trial is being conducted at Montreal, Canada.
Who is sponsoring the NCT07200323 clinical trial?
NCT07200323 is sponsored by Centre hospitalier de l'Université de Montréal (CHUM). The principal investigator is Anne Lavoie, MD at CHUM. The trial plans to enroll 100 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.